RIPK3 and metabolic dysfunction-associated steatotic liver disease: Our results show that the absence of Mlkl or Ripk3 reduced liver inflammaging and age-associated MASLD pathology; however, the absence of these proteins had differential effects on lifespan and metabolic health.